|
|
||||||||
The Annals of Thoracic Surgery, Vol 54, 93-98, Copyright © 1992 by The Society of Thoracic Surgeons
SF Bolling, MA Groh, AM Mattson, RA Grinage and KP Gallagher
To test if acadesine (5-aminoimidazole-4-carboxamide riboside), a purine
precursor, has cardioprotective effects, 16 dogs were placed on total
cardiopulmonary bypass and subjected to global myocardial ischemia.
Hemodynamic recovery was compared between a control (n = 8) group receiving
standard cardioplegia and an acadesine (n = 8) group pretreated with
intravenous acadesine (2.5 mg.kg-1.min-1 for 5 minutes, then 0.5
mg.kg-1.min-1) before ischemia, during ischemia, and until 10 minutes after
removal of the aortic cross-clamp. Additionally, in the acadesine group the
cardioplegia also contained 20 mumol/L acadesine. While the dogs were on
cardiopulmonary bypass, global warm myocardial ischemia was induced by
aortic cross-clamping for 5 minutes under normothermic conditions to
simulate an angioplasty accident. Five minutes after aortic cross-clamping,
hypothermic cardioplegia (30 mL/kg) was administered. The left anterior
descending coronary artery was occluded before the first infusion of
cardioplegia to simulate poor cardioplegia delivery that can occur during
an emergency coronary artery bypass procedure after an angioplasty
accident. The left anterior descending artery occlusion was released, and
additional cardioplegia (15 mL/kg) infusions were made every 30 minutes
thereafter during 120 minutes of cardioplegic ischemia. Thirty minutes
after reperfusion, all animals in both groups were weaned from bypass and
recovery data were obtained to compare with baseline preischemic values.
There were no significant differences in heart rate, left atrial pressure,
or systemic vascular resistance between groups after weaning from bypass.
Peak developed pressure recovered to 79% +/- 19% (mean +/- standard
deviation) of baseline in the acadesine group compared with 56% +/- 22% in
the control group (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Acadesine (AICA-riboside) improves postischemic cardiac recovery
Department of Surgery (Thoracic Surgery), University of Michigan, Ann Arbor.
This article has been cited by other articles:
![]() |
T. O. Cheng, A. Jovanovic, J. R. Lopez, A. E. Alekseev, W. K. Shen, and A. Terzic Adenosine and K+-Induced Ca2+ Loading Ann. Thorac. Surg., August 1, 1997; 64(2): 588 - 589. [Full Text] |
||||
![]() |
P. Menasche, W. R. E. Jamieson, W. Flameng, M. K. Davies, and on behalf of the Multinational Acadesine Study Gro ACADESINE: A NEW DRUG THAT MAY IMPROVE MYOCARDIAL PROTECTION IN CORONARY ARTERY BYPASS GRAFTINGResults of the first international multicenter study J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 1096 - 1106. [Abstract] [Full Text] |
||||
![]() |
E. R. Rosenkranz Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [Full Text] |
||||
![]() |
W. R. Chitwood Jr and C. L. Wixon Update in Myocardial Protection Ann. Thorac. Surg., January 1, 1995; 59(1): 253 - 254. [Full Text] |
||||
![]() |
W. D. Dietrich, L. P. Miller, R. Prado, S. Dewanjee, N. Alexis, M. K. Dewanjee, and H. Gruber Acadesine Reduces Indium-Labeled Platelet Deposition After Photothrombosis of the Common Carotid Artery in Rats Stroke, January 1, 1995; 26(1): 111 - 116. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |